SCHEMBL14748111

SCHEMBL14748111

C=CC1CC(O)C(c2ccccc2)C1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 10/20 0.41
▸ HTR2C P28335 8/20 0.41
▸ MAOA P21397 7/20 0.41
▸ KDM1A O60341 5/20 0.41
▸ CYP2C19 P33261 4/20 0.41
▸ CYP2B6 P20813 3/20 0.41
▸ CYP1A2 P05177 2/20 0.41
▸ CYP2D6 P10635 2/20 0.41
▸ CYP2C9 P11712 2/20 0.41
▸ LMNA P02545 2/20 0.41
▸ TAAR1 Q96RJ0 2/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ HTR1A P08908 1/20 0.41
▸ ADRA2A P08913 1/20 0.41
▸ CYP2A6 P11509 1/20 0.41
▸ SLC6A2 P23975 1/20 0.41
▸ ADRA1A P35348 1/20 0.41
▸ DRD3 P35462 1/20 0.41
▸ SLC6A3 Q01959 1/20 0.41
▸ KCNH2 Q12809 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1719673 0.82 MAOB (0.56) MAOBHTR2CMAOAKDM1ACYP2C19
SCHEMBL5359549 0.82 MAOB (0.56) MAOBHTR2CMAOAKDM1ACYP2C19
SCHEMBL12953786 0.82 MAOB (0.56) MAOBHTR2CMAOAKDM1ACYP2C19
SCHEMBL9461901 0.79 MAOB (0.42) MAOBHTR2CMAOAKDM1ACYP2C19
SCHEMBL27999824 0.71 HPGD (0.40) MAOBHTR2CMAOAKDM1ACYP2C19
SCHEMBL3189756 0.70 MAOB (0.48) MAOBHTR2CMAOAKDM1ACYP2C19
SCHEMBL3189760 0.70 MAOB (0.48) MAOBHTR2CMAOAKDM1ACYP2C19
SCHEMBL11379683 0.67 MAOB (0.50) MAOBHTR2CMAOAKDM1ACYP2C19
SCHEMBL25567622 0.66 SLC6A3 (0.40) MAOBHTR2CMAOAKDM1ACYP2C19
SCHEMBL3395704 0.65 HTR2C (0.57) MAOBHTR2CMAOAKDM1ACYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2170345-B1 THERAPEUTIC SUBSTITUTED CYCLOPENTANES FOR REDUCING INTRAOCULAR PRESSURE ALLERGAN INC (US) 2013-03-06 — — EP disclosed
Send feedback